Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

401 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms.
Ariey-Bonnet J, Berges R, Montero MP, Mouysset B, Piris P, Muller K, Pinna G, Failes TW, Arndt GM, Morando P, Baeza-Kallee N, Colin C, Chinot O, Braguer D, Morelli X, André N, Carré M, Tabouret E, Figarella-Branger D, Le Grand M, Pasquier E. Ariey-Bonnet J, et al. Among authors: andre n. EBioMedicine. 2023 Sep;95:104752. doi: 10.1016/j.ebiom.2023.104752. Epub 2023 Aug 10. EBioMedicine. 2023. PMID: 37572644 Free PMC article.
Conditional generation of free radicals by selective activation of alkoxyamines: towards more effective and less toxic targeting of brain tumors.
Piris P, Buric D, Yamasaki T, Huchedé P, Rossi M, Matteudi M, Montero MP, Rodallec A, Appay R, Roux C, Combes S, Pasquier E, Castets M, André N, Brémond P, Carré M. Piris P, et al. Among authors: andre n. Chem Sci. 2023 Jun 29;14(29):7988-7998. doi: 10.1039/d3sc01315d. eCollection 2023 Jul 26. Chem Sci. 2023. PMID: 37502321 Free PMC article.
Refined high-content imaging-based phenotypic drug screening in zebrafish xenografts.
Sturtzel C, Grissenberger S, Bozatzi P, Scheuringer E, Wenninger-Weinzierl A, Zajec Z, Dernovšek J, Pascoal S, Gehl V, Kutsch A, Granig A, Rifatbegovic F, Carre M, Lang A, Valtingojer I, Moll J, Lötsch D, Erhart F, Widhalm G, Surdez D, Delattre O, André N, Stampfl J, Tomašič T, Taschner-Mandl S, Distel M. Sturtzel C, et al. Among authors: andre n. NPJ Precis Oncol. 2023 May 18;7(1):44. doi: 10.1038/s41698-023-00386-9. NPJ Precis Oncol. 2023. PMID: 37202469 Free PMC article. Review.
Metastatic Melanoma in Young Child.
Min V, Petit A, Rome A, Andre N. Min V, et al. Among authors: andre n. J Pediatr Hematol Oncol. 2023 Nov 1;45(8):461-462. doi: 10.1097/MPH.0000000000002663. Epub 2023 Mar 20. J Pediatr Hematol Oncol. 2023. PMID: 37027236
Common Sense Oncology: including everyone.
André N. André N. Lancet Oncol. 2023 Oct;24(10):e402. doi: 10.1016/S1470-2045(23)00413-8. Lancet Oncol. 2023. PMID: 37797640 No abstract available.
A new generation of comprehensive precision oncology trials.
Geoerger B, Bautista F, Gatz SA, Marshall LV, André N. Geoerger B, et al. Among authors: andre n. Lancet Oncol. 2023 Dec;24(12):e452. doi: 10.1016/S1470-2045(23)00476-X. Lancet Oncol. 2023. PMID: 38039994 No abstract available.
A phase 1, first-in-child, multicenter study to evaluate the safety and efficacy of the oncolytic herpes virus talimogene laherparepvec in pediatric patients with advanced solid tumors.
Moreno L, Teira P, Croop JM, Gerber NU, André N, Aerts I, Gros Subias L, De Wilde B, Bautista F, Turpin B, Kunduri S, Hamidi A, Lawrence T, Streby KA. Moreno L, et al. Among authors: andre n. Front Pediatr. 2023 May 24;11:1183295. doi: 10.3389/fped.2023.1183295. eCollection 2023. Front Pediatr. 2023. PMID: 37292376 Free PMC article.
401 results